|
|
 |
Trial Information
Summary: Patients with Melanoma Sought for Research Study
UVa Health System, Cancer Center seeks participants advanced melanoma for a research study.
If you decide to participate in this study, you will receive paclitaxel and GMCSF given in cycles of 21 days. Each cycle is one day of paclitaxel, 14 days of GMCSF, and 4 days of rest. Participants may receive up to 12 cycles of study drugs. Treatment will be at the UVA Cancer Center and some will be administered in your home. Your blood will be drawn and tested at the UVA GCRC.
There will be up to 23 visits in 9 months. Participants will then come in every 3 months for a total of 3 years. Each visit will last up to 3 hours. No compensation is provided for this study.
Contact Information: For more information please contact: Emily Stell, CCRC (434)982-6584 or ems2b@virginia.edu IRB-HSR #11782
Principal Investigator: William Grosh, MD
www.healthsystem.virginia.edu/clinical_trials
|
Contact:
Emily M Stell BA
University of Virginia
School of Medicine Hematology/Oncology, Internal Medicine
Charlottesville, VA 22908
Telephone: 434-982-6584
Fax: --
Email:
|
|

If you would like to learn more about participating in this study, please send an e-mail message using the form below.
Please note: A number of commercial online services display an error message after you click on Send. Please be assured that your message has been received.
This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.
Trial listings updated: August 12, 2008 at 2:55:51 PM
|
 |
|